Equity Overview
Price & Market Data
Price: $0.12
Daily Change: +$0.0888 / 73.77%
Range: $0.0406 - $0.12
Market Cap: $1,727,182
Volume: 1,729
Performance Metrics
1 Week: 0.60%
1 Month: -16.46%
3 Months: 11.67%
6 Months: 24.07%
1 Year: -87.59%
YTD: 24.07%
Details
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.